Sabra Healthcare REIT, Inc. $SBRA Shares Acquired by Citigroup Inc.

Citigroup Inc. increased its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 190.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 549,769 shares of the real estate investment trust’s stock after acquiring an additional 360,619 shares during the period. Citigroup Inc. owned approximately 0.22% of Sabra Healthcare REIT worth $10,248,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of SBRA. Focus Partners Wealth boosted its position in shares of Sabra Healthcare REIT by 11.4% during the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after purchasing an additional 2,375 shares in the last quarter. Envestnet Asset Management Inc. lifted its stake in shares of Sabra Healthcare REIT by 15.5% in the second quarter. Envestnet Asset Management Inc. now owns 267,445 shares of the real estate investment trust’s stock valued at $4,932,000 after purchasing an additional 35,981 shares during the period. Assetmark Inc. boosted its holdings in Sabra Healthcare REIT by 987.2% during the second quarter. Assetmark Inc. now owns 39,216 shares of the real estate investment trust’s stock worth $723,000 after buying an additional 35,609 shares in the last quarter. Retirement Systems of Alabama grew its position in Sabra Healthcare REIT by 18.6% during the second quarter. Retirement Systems of Alabama now owns 1,170,912 shares of the real estate investment trust’s stock worth $21,592,000 after buying an additional 183,257 shares during the period. Finally, Atria Investments Inc grew its position in Sabra Healthcare REIT by 16.4% during the second quarter. Atria Investments Inc now owns 38,117 shares of the real estate investment trust’s stock worth $703,000 after buying an additional 5,375 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA opened at $20.55 on Friday. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.75 and a fifty-two week high of $21.07. The business has a fifty day moving average of $19.31 and a 200-day moving average of $18.91. The stock has a market cap of $5.18 billion, a price-to-earnings ratio of 32.11, a price-to-earnings-growth ratio of 1.65 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). The company had revenue of $201.35 million for the quarter, compared to analysts’ expectations of $201.97 million. Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The company’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.36 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Investors of record on Friday, February 13th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio is presently 187.50%.

Analyst Ratings Changes

A number of research firms have recently issued reports on SBRA. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Thursday, January 22nd. Wall Street Zen cut Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Truist Financial boosted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a research report on Tuesday, January 20th. Citigroup upped their target price on Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. Finally, Citizens Jmp lifted their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a research note on Wednesday, February 18th. Five equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $21.70.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.